Here Comes the First Approved MDMA (Ecstasy) Drug

Last week, the Multidisciplinary Association for Psychedelics Studies (MAPS) made a very big announcement: it had raised $30 million to complete its promising study of MDMA (ecstasy; molly) for treating post-traumatic stress disorder (PTSD). The Food and Drug Administration (FDA) already has granted MAPS “breakthrough therapy” approval based on earlier trials. With its recent cash

GW Pharmaceuticals: A Case Study for Cannabis FDA Approval?

In previous posts we’ve discussed the process for FDA approval of cannabis drugs. Today’s topic is GW Pharmaceuticals, a British biotech company focusing on prescription cannabinoid medicines, including developing and commercializing pharmaceutical products which address clear unmet needs. GW Pharmaceuticals was founded in the UK in 1998 by two British biotech entrepreneurs, Dr. Geoffrey Guy

European CBD Sales: Securing a Novel Food Authorization

Last year, the European Union reclassified extracts of Cannabis sativa L. and derived products containing cannabinoids, including CBD, as a “Novel Food” under the EU Novel Food Catalogue. The reclassification was based on the lack of demonstrated history of human consumption of these extracts and of any product to which they might be added. Indeed,

Why 2018 was a Tough Year for the California Cannabis Industry

2018 has been a roller coaster for California cannabis businesses. The cannabis laws and regulations in California have made life difficult, to say the least, for anyone wishing to obtain licensure. This isn’t necessarily the fault of any single legislature, municipality, or agency, but instead was the result of a perfect storm of legal and

BREAKING NEWS: City of Los Angeles Releases Draft Regulations for Marijuana Businesses

The long-awaited proposed regulations under Proposition M for L.A.’s current and future medical (and recreational) marijuana operators are finally out. The 51 pages of initial regulations (that are now in a 60-day public comment period) cover the governance of cultivators, manufacturers, distributors, testing facilities, transporters, retailers, and microbusinesses in significant detail under Proposition M. If you

Cannabis, Coronavirus and Federal Disaster Assistance

Coronavirus has been great for cannabis sales. In most states with approved cannabis programs, both medical and adult use marijuana sales have been designated “essential services” by state and local governments. With this support, the supply chain has weathered the COVID-19 pandemic better than many industries. Still, the pandemic continues unabated and cannabis businesses are

China Manufacturing:"Elvis Has Left the Building"

Though “Phase One” of a US-China trade deal is set to be signed next week, few believe that will end the ongoing trade and restrictions war between China and the United States. In China’s manufacturing exodus set to continue in 2020, despite prospect of trade war deal, the South China Morning Post (owned by Alibaba),

China and the West Are Decoupling: Please Act Accordingly

 The US-China Trade War is and will be the new normal. Relations between the EU and China are soomewhat better, but those are quickly getting worse as well. If you are doing business in China or with China you should at least once every day look in a mirror and say this: Relations between

Reduce China Exposure and Make Taiwan Great Again

As countries around the world seek to reduce their exposure to China, Taiwan finds itself in the center of the process. I just spent two months in Kaohsiung, Taiwan (working on a large multi-country project involving China, Taiwan and Indonesia) and during my time there I heard much about Taiwan’s response to the trade crisis.

Hold Your Horses: Los Angeles EMMDs Will Soon be Prevented from Relocating

Los Angeles’s existing medical marijuana dispensaries (“EMMDs”) under Measure M will soon be precluded from relocating from their current operations unless and until they receive their local annual licenses from the City of Los Angeles. Movement post-initial application to L.A. has been a common practice for  EMMDs for some time, and has apparently caused a